Extracorporal Shock Wave Treatment to Improve Nerve Regeneration

Status Recruiting

Clinical Trial Summary

This study evaluates the impact of extracorporeal shock wave treatment after microsurgical coaptation of finger nerves. Participants will be randomized into two treatment groups with different settings and a sham group. The participants will thereafter followed-up in a prospective, double-blind study design.

Clinical Trial Description

Extracorporeal shock wave treatment is CE certified in Austria, Europe and licensed for indications like achillodynia, epicondylitis, or tendinitis calcanea. The Orthogold 100 device by MTS Medical UG will be used for this study. Defocused low-energy extracorporeal shock wave therapy (ESWT) has gained acceptance as a therapeutic tool in different medical settings. It has been shown, that shock waves stimulate of the metabolic activity of different cell type, including osteoblasts, tenocytes, endothelial cells and chondrocytes. Furthermore, it has proved effective in clinical applications relating to bone and wound healing and myocardial ischaemia. Until now, no studies have been performed regarding the effects of ESWT on regeneration of peripheral nerve injuries in humans. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03147313
Study type	Interventional
Source	Ludwig Boltzmann Gesellschaft
Contact	Rudolf Rosenauer, M.D.
Phone	0043 59393 41270
Email	rudolf.rosenauer@auva.at
Status	Recruiting
Phase	N/A
Start date	April 18, 2017
Completion date	June 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02359825` - Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function	Phase 1
Not yet recruiting	`NCT02865317` - Cortical Effects of Peripheral Nerve Injury At Birth	N/A
Recruiting	`NCT01554722` - Needle Nerve Contact in Ultrasound Guided Femoral Block	N/A
Recruiting	`NCT06071988` - Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy	Phase 3
Recruiting	`NCT06071936` - Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy	Phase 3
Recruiting	`NCT05541250` - Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)	Phase 1
Recruiting	`NCT06209632` - Mirror Therapy Combined With Contralaterally Controlled Functional Electrical Stimulation for Peripheral Nerve Injury	N/A
Completed	`NCT01116362` - Comparing Primary With Secondary Repair of Based on Electrodiagnostic Assessment and Clinical Examination	Phase 2
Withdrawn	`NCT04270019` - Polyethylene Glycol to Improve Sensation Following Digital Nerve Laceration	Phase 1/Phase 2
Completed	`NCT01302275` - Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain	Phase 4
Terminated	`NCT01088256` - Efficacy of Etoricoxib on Peripheral Hyperalgesia	Phase 2
Completed	`NCT02228928` - Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain	Phase 1/Phase 2
Withdrawn	`NCT00950391` - Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus	Phase 1/Phase 2
Completed	`NCT00953277` - Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer	Phase 4
Not yet recruiting	`NCT06003166` - 4-AP Peripheral Nerve Crossover Trial	Phase 3
Not yet recruiting	`NCT02666456` - The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain	N/A
Not yet recruiting	`NCT02352649` - Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Peripheral Nerve Injury	Phase 1/Phase 2
Terminated	`NCT02034461` - Micro-Electrodes Implanted in a Human Nerve	N/A
Completed	`NCT01596491` - Study of Possible Changes in QST After Application of Capsaicin on Patients With Peripheral Neuropathic Pain	N/A